On May 27, 2015 the Board of Directors has resolved, pursuant to the authorisation granted by the annual meeting held on March 23, 2015, on a directed issue of 1,799,999 new shares at a subscription price of SEK 139 per share. The subscription price represents a premium of approximately 3 per cent compared to the 5 to 20 days volume weighted average closing price prior to the Board of Directors’ resolution, and a discount of approximately 4 per cent compared to the closing price on May 27, 2015.
The proceeds from the directed issue will be used to finance and facilitate accelerated expansion, acquisition opportunities and development of the Company, its markets and products.
The Board considers it positive that the First AP-fund becomes a new major shareholder of the Company. The first AP-fund represents a committed and long-term institutional owner which the Board believes will contribute positively to the Company’s development. The new share issue represents an opportunity for the Company to raise capital efficiently and on favourable terms, for the above-mentioned purposes, and thus enhances the Company’s opportunities to create additional value for all shareholders.
The new issue results in a share dilution of approximately 8.8 per cent. Through the issue, the number of shares in Arcam increases by 1 799 999 from 18 665 240 to 20 465 239 and the share capital increases by SEK 1799 999.14 from SEK 18 665 241.50 to SEK 20 465 240.64.
Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the constituent information in accordance with the rules and regulations prevailing in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Arcam AB (publ) securities in any jurisdiction, neither from Arcam AB (publ) nor anyone else.
The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on 28 May 2015 at 8.30 AM.
Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components. Arcam’s Electron Beam Melting (EBM®) technology offers design freedom combined with excellent material properties and high productivity. Arcam is, through its solution orientation and comprehensive product offering, an innovative partner for advanced manufacturing, primarily for the aerospace and medical industries. Arcam offers EBM systems through Arcam AB in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DiSanto in the U.S.The company is listed on Nasdaq Stockholm and the Head Office is located in Mölndal, Sweden.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com
Source version on businesswire